Bone cancer risk estimates.
Due to confusion between endosteal (bone surface) dose and average skeletal dose, ICRP 60 has substantially overestimated the risk of radiogenic bone cancer. This confusion apparently stems from an incorrect reading of the BEIR IV report, which does not clearly draw this distinction. It should also be noted that what appear to be summary numerical risk estimates for bone sarcoma induction in BEIR IV and BEIR V refer only to average skeletal dose as calculated for 224Ra.
Puskin
J S
JS
U.S. Environmental Protection Agency, Washington, D.C. 20460.
Nelson
N S
NS
Nelson
C B
CB
D001859:Bone Neoplasms / Q000453:epidemiology* / Q000209:etiology*; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology*; D012516:Osteosarcoma / Q000453:epidemiology* / Q000209:etiology*; D011829:Radiation Dosage; D012307:Risk Factors